XKRX:298380 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
33,800
-800 (-2.31%)
Mar 27
What is a stock summary page? Click here for an overview.
Business Description
ABL Bio Inc
ISIN : KR7298380007
Share Class Description:
XKRX:298380: Ordinary SharesCompare
Compare
Traded in other countries / regions
298380.Korea Index Membership
KOSDAQ Composite Index IPO Date
2018-12-19Description
ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.24 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | -0.82 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 15.08 | |||||
| Beneish M-Score | 1.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 83 | |||||
| 3-Year EBITDA Growth Rate | -7.9 | |||||
| 3-Year EPS without NRI Growth Rate | -2.9 | |||||
| 3-Year FCF Growth Rate | -22.4 | |||||
| 3-Year Book Growth Rate | 42.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.22 | |||||
| 9-Day RSI | 32.31 | |||||
| 14-Day RSI | 39.04 | |||||
| 3-1 Month Momentum % | 44.82 | |||||
| 6-1 Month Momentum % | 36.65 | |||||
| 12-1 Month Momentum % | 64.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.28 | |||||
| Quick Ratio | 2.28 | |||||
| Cash Ratio | 2.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.7 | |||||
| Shareholder Yield % | -7.73 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -177.56 | |||||
| Net Margin % | -166.24 | |||||
| FCF Margin % | -234.89 | |||||
| ROE % | -51.5 | |||||
| ROA % | -30.91 | |||||
| ROIC % | -52.64 | |||||
| 3-Year ROIIC % | -7.07 | |||||
| ROC (Joel Greenblatt) % | -68.97 | |||||
| ROCE % | -38.7 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 135.78 | |||||
| PS Ratio | 48.61 | |||||
| PB Ratio | 9.88 | |||||
| Price-to-Tangible-Book | 10.02 | |||||
| EV-to-EBIT | -28.24 | |||||
| EV-to-EBITDA | -29.52 | |||||
| EV-to-Revenue | 46.92 | |||||
| EV-to-FCF | -23.13 | |||||
| Price-to-GF-Value | 1.46 | |||||
| Price-to-Net-Current-Asset-Value | 21.21 | |||||
| Price-to-Net-Cash | 21.14 | |||||
| Earnings Yield (Greenblatt) % | -3.55 | |||||
| FCF Yield % | -4.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ABL Bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 33,403.031 | ||
| EPS (TTM) (â‚©) | -1156 | ||
| Beta | 0.85 | ||
| 3-Year Sharpe Ratio | 0.46 | ||
| 3-Year Sortino Ratio | 0.78 | ||
| Volatility % | 59.39 | ||
| 14-Day RSI | 39.04 | ||
| 14-Day ATR (â‚©) | 2584.504196 | ||
| 20-Day SMA (â‚©) | 38905 | ||
| 12-1 Month Momentum % | 64.14 | ||
| 52-Week Range (â‚©) | 21200 - 47250 | ||
| Shares Outstanding (Mil) | 48.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ABL Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ABL Bio Inc Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
ABL Bio Inc Frequently Asked Questions
What is ABL Bio Inc(XKRX:298380)'s stock price today?
The current price of XKRX:298380 is â‚©33800.00. The 52 week high of XKRX:298380 is â‚©47250.00 and 52 week low is â‚©21200.00.
When is next earnings date of ABL Bio Inc(XKRX:298380)?
The next earnings date of ABL Bio Inc(XKRX:298380) is 2025-05-14 Est..
Does ABL Bio Inc(XKRX:298380) pay dividends? If so, how much?
ABL Bio Inc(XKRX:298380) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers